Immunic, Inc.
DE ˙ DB
€16,63 ↓ -16,55 (-49,87%)
2019-04-18
HİSSE FİYATI
SecurityDE:10V / Immunic, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership522,797 shares
Latest Disclosed Value $ 580,305
UBS Group AG reports 2.67% decrease in ownership of 10V / Immunic, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 522,797 shares of Immunic, Inc. (DE:10V) valued at $580,305 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 537,118 shares of Immunic, Inc.. This represents a change in shares of -2.67% during the quarter. The current value of the position is $8,695,160 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F IMMUNIC COM 4525EP101 522,797 -14,321 -2.67 580 102.80 0.0000
2026-01-29 2025-12-31 13F IMMUNIC COM 4525EP101 537,118 498,431 1,288.37 287 741.18 0.0000
2025-11-13 2025-09-30 13F IMMUNIC COM 4525EP101 38,687 -337,417 -89.71 34 -87.02 0.0000
2025-08-14 2025-06-30 13F IMMUNIC COM 4525EP101 376,104 227,054 152.33 263 61.73 0.0000
2025-05-13 2025-03-31 13F IMMUNIC COM 4525EP101 149,050 121,853 448.04 162 500.00 0.0000
2025-02-14 2024-12-31 13F IMMUNIC COM 4525EP101 27,197 24,758 1,015.09 27 575.00 0.0000
2024-11-14 2024-09-30 13F IMMUNIC COM 4525EP101 2,439 1,085 80.13 4 300.00 0.0000
2024-08-14 2024-06-30 13F IMMUNIC COM 4525EP101 1,354 -7,813 -85.23 2 -91.67 0.0000
2024-05-13 2024-03-31 13F IMMUNIC COM 4525EP101 9,167 -1,214 -11.69 12 -20.00 0.0000
2024-02-09 2023-12-31 13F IMMUNIC COM 4525EP101 10,381 7,297 236.61 16 275.00 0.0000
2023-11-09 2023-09-30 13F IMMUNIC COM 4525EP101 3,084 3,059 12,236.00 5 0.0000
2023-08-11 2023-06-30 13F IMMUNIC COM 4525EP101 25 -9,997 -99.75 0 -100.00 0.0000
2023-05-12 2023-03-31 13F IMMUNIC COM 4525EP101 10,022 9,997 39,988.00 15 0.0000
2023-02-08 2022-12-31 13F IMMUNIC COM 4525EP101 25 -3,747 -99.34 0 -100.00 0.0000
2022-11-10 2022-09-30 13F IMMUNIC COM 4525EP101 3,772 -69,793 -94.87 12 -95.29 0.0000
2022-08-10 2022-06-30 13F IMMUNIC COM 4525EP101 73,565 72,832 9,936.15 255 3,087.50 0.0001
2022-05-16 2022-03-31 13F IMMUNIC COM 4525EP101 733 -4,384 -85.68 8 -83.67 0.0000
2022-02-14 2021-12-31 13F IMMUNIC COM 4525EP101 5,117 2,919 132.80 49 157.89 0.0000
2021-11-15 2021-09-30 13F IMMUNIC COM 4525EP101 2,198 -1,423 -39.30 19 -56.82 0.0000
2021-08-13 2021-06-30 13F IMMUNIC COM 4525EP101 3,621 3,621 44 0.0000
2021-02-11 2020-12-31 13F IMMUNIC COM 4525EP101 0 -1,953 -100.00 0 -100.00
2020-11-12 2020-09-30 13F IMMUNIC COM 4525EP101 1,953 892 84.07 36 176.92 0.0000
2020-07-31 2020-06-30 13F IMMUNIC COM 4525EP101 1,061 -2,141 -66.86 13 -31.58 0.0000
2020-05-01 2020-03-31 13F IMMUNIC COM 4525EP101 3,202 3,202 201.79 19 46.15 0.0000
2019-11-14 2019-09-30 13F IMMUNIC COM 4525EP101 0 -429 -100.00 0 -100.00
2019-08-14 2019-06-30 13F IMMUNIC COM 4525EP101 429 429 5 0.0000
2019-05-14 2019-03-31 13F VITAL THERAPIES COM 92847R104 0 -78,871 -100.00 0 -100.00
2019-02-14 2018-12-31 13F VITAL THERAPIES COM 92847R104 78,871 53,858 215.32 15 114.29 0.0000
2018-11-14 2018-09-30 13F VITAL THERAPIES COM 92847R104 25,013 23,442 1,492.17 7 -36.36 0.0000
2018-08-14 2018-06-30 13F VITAL THERAPIES COM 92847R104 1,571 1,571 -93.72 11 57.14 0.0000
2018-05-15 2018-03-31 13F VITAL THERAPIES COM 92847R104 0 -5,544 -100.00 0 -100.00
2018-02-14 2017-12-31 13F VITAL THERAPIES COM 92847R104 5,544 5,544 33 0.0000
2017-11-14 2017-09-30 13F VITAL THERAPIES COM 92847R104 0 -346 -100.00 0 -100.00
2017-11-14 2017-06-30 13F/A-1 VITAL THERAPIES COM 92847R104 346 -3,863 -91.78 1 -94.12 0.0000
2017-08-14 2017-06-30 13F VITAL THERAPIES COM 92847R104 346 -3,863 1
2017-11-14 2017-03-31 13F/A-1 VITAL THERAPIES COM 92847R104 4,209 643 18.03 17 13.33 0.0000
2017-05-12 2017-03-31 13F VITAL THERAPIES COM 92847R104 4,209 643 17
2017-02-14 2016-12-31 13F VITAL THERAPIES COM 92847R104 3,566 3,096 658.72 15 400.00 0.0000
2016-11-14 2016-09-30 13F VITAL THERAPIES COM 92847R104 470 470 -86.82 3 -80.00 0.0000
2016-08-12 2016-06-30 13F VITAL THERAPIES COM 92847R104 0 -1,801 -100.00 0 -100.00
2016-05-12 2016-03-31 13F VITAL THERAPIES COM 92847R104 1,801 1,567 669.66 16 433.33 0.0000
2016-02-16 2015-12-31 13F VITAL THERAPIES COM 92847R104 234 -1,988 -89.47 3 -66.67 0.0000
2015-11-13 2015-09-30 13F VITAL THERAPIES COM 92847R104 2,222 1,072 93.22 9 -62.50 0.0000
2015-08-14 2015-06-30 13F VITAL THERAPIES COM 92847R104 1,150 -126 -9.87 24 -25.00 0.0000
2015-05-14 2015-03-31 13F VITAL THERAPIES COM 92847R104 1,276 -976 -43.34 32 -42.86 0.0000
2015-02-17 2014-12-31 13F VITAL THERAPIES COM 92847R104 2,252 2,252 56 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.